Home LiteratureArticle Details
PMID: 19255141 Published · ppublish English Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability.

Molecular and cellular biology ·Vol. 29 ·No. 9 ·2009-05-00 ·Pages 2469-80

Gavard J, Hou X, Qu Y, Masedunskas A, Martin D, Weigert R, Li X, Gutkind JS

Abstract

Most proangiogenic polypeptide growth factors and chemokines enhance vascular permeability, including vascular endothelial growth factor (VEGF), the main target for anti-angiogenic-based therapies, and interleukin-8 (IL-8), a potent proinflammatory mediator. Here, we show that in endothelial cells IL-8 initiates a signaling route that converges with that deployed by VEGF at the level of the small GTPase Rac1 and that both act through the p21-activated kinase to promote the phosphorylation and internalization of VE-cadherin. However, whereas VEGF activates Rac1 through Src-related kinases, IL-8 specifically signals to Rac1 through its cognate G protein-linked receptor, CXCR2, and the stimulation of the phosphatidylinositol 3-kinase gamma (PI3Kgamma) catalytic isoform, thereby providing a specific molecular targeted intervention in vascular permeability. These results prompted us to investigate the potential role of IL-8 signaling in a mouse model for retinal vascular hyperpermeability. Importantly, we observed that IL-8 is upregulated upon laser-induced retinal damage, which recapitulates enhanced vascularization, leakage, and inflammatory responses. Moreover, blockade of CXCR2 and PI3Kgamma was able to limit neovascularization and choroidal edema, as well as macrophage infiltration, therefore contributing to reduce retinal damage. These findings indicate that the CXCR2 and PI3Kgamma signaling pathway may represent a suitable target for the development of novel therapeutic strategies for human diseases characterized by vascular leakage.

MeSH Terms
Animals Antigens, CD/metabolism Cadherins/metabolism Capillary Permeability Cell Line Class Ib Phosphatidylinositol 3-Kinase Female Humans Interleukin-8/metabolism Isoenzymes/genetics,metabolism Lasers/adverse effects Male Mice Mice, Inbred C57BL Mice, Nude Phosphatidylinositol 3-Kinases/genetics,metabolism Rats Rats, Sprague-Dawley Receptors, Interleukin-8B/genetics,metabolism Retinal Vessels/metabolism,pathology Signal Transduction/physiology Vascular Endothelial Growth Factor A/metabolism rac1 GTP-Binding Protein/genetics,metabolism
Chemicals
Antigens, CD Cadherins Interleukin-8 Isoenzymes Receptors, Interleukin-8B Vascular Endothelial Growth Factor A cadherin 5 Phosphatidylinositol 3-Kinases Class Ib Phosphatidylinositol 3-Kinase PIK3CG protein, human Pik3cg protein, mouse rac1 GTP-Binding Protein
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Gavard Julie
Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Bethesda, MD 20892, USA. julie.gavard@inserm.fr
Hou Xu
Qu Yi
Masedunskas Andrius
Martin Daniel
Weigert Roberto
Li Xuri
Gutkind J Silvio
References (53)
53 references, click to expand
  1. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration.
    J Biol Chem. 1998 Apr 24;273(17):10095-8 PMID: 9553055
  2. VEGF receptor signalling - in control of vascular function.
    Nat Rev Mol Cell Biol. 2006 May;7(5):359-71 PMID: 16633338
  3. VEGF inhibition and renal thrombotic microangiopathy.
    N Engl J Med. 2008 Mar 13;358(11):1129-36 PMID: 18337603
  4. An essential role for Rac1 in endothelial cell function and vascular development.
    FASEB J. 2008 Jun;22(6):1829-38 PMID: 18245172
  5. Cancer and the chemokine network.
    Nat Rev Cancer. 2004 Jul;4(7):540-50 PMID: 15229479
  6. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5.
    Nat Cell Biol. 2008 Aug;10(8):923-34 PMID: 18604199
  7. Permanent cell line expressing human factor VIII-related antigen established by hybridization.
    Proc Natl Acad Sci U S A. 1983 Jun;80(12):3734-7 PMID: 6407019
  8. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction.
    J Clin Invest. 2004 Mar;113(6):885-94 PMID: 15067321
  9. The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis.
    Mol Cell. 2004 Apr 9;14(1):29-41 PMID: 15068801
  10. Fibrosis and diseases of the eye.
    J Clin Invest. 2007 Mar;117(3):576-86 PMID: 17332885
  11. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus.
    Nat Med. 2005 Sep;11(9):933-5 PMID: 16127435
  12. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis.
    J Cell Biol. 2004 Oct 25;167(2):223-9 PMID: 15504909
  13. Mechanisms of adverse effects of anti-VEGF therapy for cancer.
    Br J Cancer. 2007 Jun 18;96(12):1788-95 PMID: 17519900
  14. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin.
    Nat Cell Biol. 2006 Nov;8(11):1223-34 PMID: 17060906
  15. Endothelial cell-cell junctions: happy together.
    Nat Rev Mol Cell Biol. 2004 Apr;5(4):261-70 PMID: 15071551
  16. Leukocyte phosphoinositide-3 kinase {gamma} is required for chemokine-induced, sustained adhesion under flow in vivo.
    J Leukoc Biol. 2006 Dec;80(6):1491-9 PMID: 16997858
  17. Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung.
    J Clin Invest. 2006 Mar;116(3):695-702 PMID: 16485040
  18. PI3Kgamma inhibition: towards an 'aspirin of the 21st century'?
    Nat Rev Drug Discov. 2006 Nov;5(11):903-18 PMID: 17080027
  19. Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis.
    Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):967-72 PMID: 17210921
  20. Pathophysiological consequences of VEGF-induced vascular permeability.
    Nature. 2005 Sep 22;437(7058):497-504 PMID: 16177780
  21. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.
    Nat Med. 2005 Sep;11(9):936-43 PMID: 16127437
  22. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice.
    Nat Med. 2003 Nov;9(11):1390-7 PMID: 14566334
  23. Clinical update: new treatments for age-related macular degeneration.
    Lancet. 2007 Jul 21;370(9583):204-206 PMID: 17658379
  24. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis.
    J Immunol. 2003 Mar 15;170(6):3369-76 PMID: 12626597
  25. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
    Science. 1983 Feb 25;219(4587):983-5 PMID: 6823562
  26. VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2.
    Exp Cell Res. 2007 Sep 10;313(15):3285-97 PMID: 17686471
  27. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
    Thromb Haemost. 2008 Feb;99(2):279-85 PMID: 18278175
  28. Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.
    Cancer Res. 2007 Aug 1;67(15):7358-67 PMID: 17671206
  29. Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability.
    Mol Biol Cell. 2007 Dec;18(12):5014-23 PMID: 17928406
  30. A betaPix Pak2a signaling pathway regulates cerebral vascular stability in zebrafish.
    Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):13990-5 PMID: 17573532
  31. Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice.
    J Clin Invest. 2007 Nov;117(11):3421-6 PMID: 17975672
  32. Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.
    J Clin Invest. 2008 Jun;118(6):2337-46 PMID: 18483622
  33. Angiogenesis in life, disease and medicine.
    Nature. 2005 Dec 15;438(7070):932-6 PMID: 16355210
  34. Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury.
    Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19866-71 PMID: 17172449
  35. CXC chemokines in angiogenesis.
    J Leukoc Biol. 2000 Jul;68(1):1-8 PMID: 10914483
  36. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke.
    Nat Med. 2001 Feb;7(2):222-7 PMID: 11175854
  37. Phosphoinositide 3-kinases as targets for therapeutic intervention.
    Curr Pharm Des. 2004;10(16):1915-22 PMID: 15180528
  38. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
    J Immunol. 2000 Nov 1;165(9):5269-77 PMID: 11046061
  39. CXCR2--the receptor to hit?
    Drug News Perspect. 2006 Dec;19(10):615-23 PMID: 17299604
  40. Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors.
    J Clin Invest. 2005 Jan;115(1):118-27 PMID: 15630451
  41. Endothelium-microenvironment interactions in the developing embryo and in the adult.
    Dev Cell. 2007 Feb;12(2):181-94 PMID: 17276337
  42. VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats.
    J Clin Invest. 2008 Mar;118(3):913-23 PMID: 18259607
  43. Angiogenesis.
    Annu Rev Med. 2006;57:1-18 PMID: 16409133
  44. p21-activated kinase regulates endothelial permeability through modulation of contractility.
    J Biol Chem. 2004 Nov 5;279(45):46621-30 PMID: 15333633
  45. Interleukin-8 as a macrophage-derived mediator of angiogenesis.
    Science. 1992 Dec 11;258(5089):1798-801 PMID: 1281554
  46. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis.
    J Leukoc Biol. 2006 Dec;80(6):1183-96 PMID: 16997855
  47. Interleukin-8. A corneal factor that induces neovascularization.
    Am J Pathol. 1992 Dec;141(6):1279-84 PMID: 1281615
  48. Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis.
    J Cell Biol. 2007 Feb 26;176(5):719-27 PMID: 17312022
  49. Neutrophils promote experimental choroidal neovascularization.
    Mol Vis. 2005 Jun 16;11:414-24 PMID: 15988410
  50. Pegaptanib for neovascular age-related macular degeneration.
    N Engl J Med. 2004 Dec 30;351(27):2805-16 PMID: 15625332
  51. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia.
    Dev Cell. 2008 Jan;14(1):25-36 PMID: 18194650
  52. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.
    Cell. 2007 Nov 2;131(3):463-75 PMID: 17981115
  53. Autocrine VEGF signaling is required for vascular homeostasis.
    Cell. 2007 Aug 24;130(4):691-703 PMID: 17719546
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
1098-5549
Published
2009-05-00
Epub
2009-00-02
Pages
2469-80
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC2668372
Subset
IM
Grants
Intramural NIH HHS · Z99 EY999999 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com